Nick Dunster

Nick Dunster joined the Trust in 2005 and is responsible for contract negotiations, due diligence and IP issues.
He monitors existing investments in drug discovery, vaccine trials, medical devices and platform technologies, and holds two Board Observer positions.
He obtained a first degree in biochemistry from the University of Bristol, a PhD from Cambridge and has six years' experience in the biotech industry with focus on cancer, immunology and anti-infective preclinical drug discovery.